2022
DOI: 10.1080/21655979.2022.2066753
|View full text |Cite
|
Sign up to set email alerts
|

Sufentanil alleviates pre-eclampsia via silencing microRNA-24-3p to target 11β-Hydroxysteroid dehydrogenase type 2

Abstract: Pre-eclampsia (PE) is a prevalent pregnancy disease characterized by insufficient trophoblast cell migration (HTR8/SVneo). Consequently, accelerating trophoblast cell proliferation might ameliorate PE. This study assessed the effects and molecular mechanisms of Sufentanil (SUF) on HTR8/SVneo cells proliferation. HTR8/SVneo cells and PE clinical samples were used. Peripheral blood was collected from PE patients’ samples, and microRNA (miR)-24-3p and 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2) was analyzed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 29 publications
0
4
0
Order By: Relevance
“…Future targets for analysis might include proteins confirmed to have a positive [p38 Mitogen-activated protein kinases (MAPK)], or negative [extracellular signal-regulated kinase (ERK)1/2 MAPK], effect on the regulation of placental 11 β -HSD2 [ 85 ]. Medications known to alter DNA methylation or histone modifications as well as non-coding RNAs (e.g., miR-24-3p) may also provide indirect changes in the regulation of 11 β -HSD2 [ 86 , 87 ], highlighting another area for future studies. Future studies should also link placental biomarkers to higher-order deficits and secondary disabilities in children with PAE (e.g., executive functioning, impulsivity, metabolic disorder, obesity) and examine the sensitivity and specificity of placenta and cord blood biomarkers with respect to these long-term outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…Future targets for analysis might include proteins confirmed to have a positive [p38 Mitogen-activated protein kinases (MAPK)], or negative [extracellular signal-regulated kinase (ERK)1/2 MAPK], effect on the regulation of placental 11 β -HSD2 [ 85 ]. Medications known to alter DNA methylation or histone modifications as well as non-coding RNAs (e.g., miR-24-3p) may also provide indirect changes in the regulation of 11 β -HSD2 [ 86 , 87 ], highlighting another area for future studies. Future studies should also link placental biomarkers to higher-order deficits and secondary disabilities in children with PAE (e.g., executive functioning, impulsivity, metabolic disorder, obesity) and examine the sensitivity and specificity of placenta and cord blood biomarkers with respect to these long-term outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…This review summarized miRNAs that target corresponding mRNAs and regulate the biological function of trophoblasts in pregnancy disorders, including trophoblast cell invasion, proliferation, migration, differentiation, apoptosis, autophagy, pyroptosis, ferroptosis, cellular metabolism, and angiogenesis through different pathways. Proper function of the trophoblast is essential for embryonic development, while the abnormal function of the trophoblast may lead to pregnancy disorders [ 190 , 191 ]. Of note, pyroptosis and ferroptosis are the most studied programmed cell death modes in recent years, but few studies have investigated the regulation of miRNAs in pregnancy disorders by regulating pyroptosis and ferroptosis of trophoblast cells.…”
Section: Discussionmentioning
confidence: 99%
“…It is interesting to note that the differential expression of lncRNA and circRNA is closely related to the occurrence and development of pregnancy disorders [ 190 , 191 , 194 ]. For example, so far, lncRNA H19 (H19) is one of the most thoroughly studied lncRNAs [ 195 ], and H19 is closely related to the occurrence and development of PE and IUGR [ 192 , 196 , 197 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation